Clinical Genomics Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 56
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $26M
Latest Deal Amount
  • Investors
  • 5

Clinical Genomics General Information

Description

Developer of a diagnostic platform designed to improve patient outcomes through early detection of colorectal cancer. The company's platform provides a blood test for detecting colorectal cancer based on methylated DNA from two genes, BCAT1 and IKZF1, and plans to offer this 2-gene test for CRC recurrence monitoring, enabling patients to begin treatment as soon as possible, resulting in a good medical outcome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 1031 US Highway 202/206
  • Suite 100
  • Bridgewater, NJ 08807
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Clinical Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 01-Jun-2018 $26M 0000 Completed Generating Revenue
3. Later Stage VC 00.000 0000 Completed Generating Revenue
2. Debt - General $650K $15.7M Completed Generating Revenue
1. Later Stage VC (Series A) 23-Mar-2016 $15M $15M Completed Generating Revenue
To view Clinical Genomics’s complete valuation and funding history, request access »

Clinical Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a diagnostic platform designed to improve patient outcomes through early detection of colorectal cancer. Th
Diagnostic Equipment
Bridgewater, NJ
56 As of 2022
0000
00000000000 0000

00000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000 000000000
Saint Louis, MO
00 As of 0000
00.00
00000000000 00.00

00000 00

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
0000000000 000000000
Madison, WI
0000 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Clinical Genomics Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Geneoscopy Venture Capital-Backed Saint Louis, MO 00 00.00 00000000000 00.00
00000 00000000 Formerly VC-backed Madison, WI 0000 00.000 00000000 00.000
00000 Formerly VC-backed Menlo Park, CA 000 000 000000&0 000
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
00000000 Venture Capital-Backed Seattle, WA 00 0000 00000000000 0000
You’re viewing 5 of 26 competitors. Get the full list »

Clinical Genomics Patents

Clinical Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019200359-A1 Screening method Pending 18-Jan-2019 0000000000
AU-2020209763-A1 Screening method Pending 18-Jan-2019 000000000000
EP-3911764-A1 Screening method Pending 18-Jan-2019 0000000000
JP-2020534820-A Methods for methylation analysis Pending 15-Sep-2017 0000000000
AU-2018333844-A1 Method for methylation analysis Pending 15-Sep-2017 C12Q1/686
To view Clinical Genomics’s complete patent history, request access »

Clinical Genomics Executive Team (18)

Name Title Board Seat Contact Info
Michael Paris Chief Operating Officer & Chief Executive Officer
Betty Lui General Manager
Susanne Pedersen Ph.D Co-Founder, Chief Scientific Officer & Vice President, Science & Innovation
Edward Rosen Chief Strategy and Commercial Officer
Lawrence LaPointe Ph.D Co-Founder & Scientific Advisor
You’re viewing 5 of 18 executive team members. Get the full list »

Clinical Genomics Board Members (8)

Name Representing Role Since
Grant Chamberlain OneVentures Board Member 000 0000
Nicholas Conti Ph.D Self Board Member 000 0000
Peter Jollie Self Board Member 000 0000
Robert Mawhinney Clinical Genomics Co-Founder & Chairman 000 0000
Roy Davis Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Clinical Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clinical Genomics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MA Financial PE/Buyout Minority 000 0000 000000 0
Prisma (Australia) Family Office Minority 000 0000 000000 0
Regal Venture Capital Venture Capital Minority 000 0000 000000 0
OneVentures Venture Capital Minority 000 0000 000000 0
Quest Diagnostics Corporation Minority 000 0000 000000 0
To view Clinical Genomics’s complete investors history, request access »

Clinical Genomics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 30-Sep-2013 0000000000 Biotechnology
To view Clinical Genomics’s complete acquisitions history, request access »

Clinical Genomics Subsidiaries (1)

Company Name Industry Location Founded
00000 00000000000 Biotechnology Edison, NJ 0000
To view Clinical Genomics’s complete subsidiaries history, request access »